YMTX - Yumanity Therapeutics GAAP EPS of -$0.31 revenue of $1.4M November, 14 2022 08:57 AM Yumanity Therapeutics Inc. Yumanity Therapeutics press release ( NASDAQ: YMTX ): Q3 GAAP EPS of -$0.31. Revenue of $1.4M (-14.6% Y/Y). For further details see: Yumanity Therapeutics GAAP EPS of -$0.31, revenue of $1.4M